Close
Xylem
Novotech

ABITEC Corporation and IMCD Announce Specialty Lipid Distribution Agreement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development

Novartis has finalized a significant collaboration agreement with Antares...
- Advertisement -

US ingredients conglomerate announces new partnership to distribute specialty lipids into theย pharmaceutical and nutritional markets in Asia and South America.

ABITEC Corporation has executed a multi-year agreement with distribution partner IMCD, toย promote and sell its specialty lipid products into the Brazil, China, India, and Taiwan markets. Theย arrangement strengthens an already existing relationship between the two companies and aims toย fulfill market innovation and customer demand requirements for ABITECโ€™s functional lipid productsย in these new locales.

Neil Houston, Director of Pharmaceuticals Americas-IMCD, notes, โ€œThe expansion of ourย relationship with ABITEC is an excellent fit with our business as we continue to align with world classย suppliers of pharmaceutical ingredients on a multi-regional basis. We recognize ABITECโ€™s portfolio ofย unique lipids as being a vital ingredient to provide our customers with formulation solutions,particularly with poorly soluble API’s.โ€ย 

Dr. Donald Kelemen, Head of Corporate Development-ABITEC states “ABITEC’s relationship withย IMCD has quickly transitioned into an effective and mutually beneficial partnership centered onย trust, a shared common vision and commercial growth. In addition to having access to their globalย teams of highly trained scientists, IMCD provides ABITEC with an understanding of local marketย dynamics. Together, this agreement will allow both companies to expand our presence in markets ofย growing world economies and will greatly assist regional and multinational pharmaceutical andย nutritional companies to develop products of the highest quality for their customers.”ย 

ABITECโ€™s specialty lipids include CAPMULยฎ, CAPTEXยฎ, CAPROLยฎ, ACCONONยฎ, NUTRI SPERSEยฎ andย PURECOยฎ and can be used for a variety of applications, including pharmaceutical, nutritional andย cosmetic products, as well as in the manufacturing of foams, creams, ointments and lotions.ย 

For further information, please contact:
Amanda Coulter, Manager: Marketing Research and Communicationsย 
614-429-6453 | acoulter@abiteccorp.com
www.abiteccorp.com

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development

Novartis has finalized a significant collaboration agreement with Antares...

4 Health Supplement Brands Using Science-Backed Ingredients

Most supplement shoppers don't realize how wide the gap...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป